Buscar
Congreso SOLACI
HomeEuroPCR 2015.Day 2

Day 2

Ver Categoría
Day 2

NONSTEMI: Superiority of early angioplasty in non-ST elevation myocardial infarction

The European guidelines recommend revascularization within 24 hours in high-risk patients with No ST segment elevation myocardial...
solaci -
Ver más
Day 2

TOTAL stroke: increased risk of stroke with thromboaspiration

There are many doubts about the benefit of manual thromboaspiration, not only in terms of improvement of...
solaci -
Ver más
Day 2

PARTNER II: Less oversizing to reduce paravalvular failure with the new generation of SAPIEN 3

The new generation SAPIEN 3 valve was designed to reduce paravalvular aortic regurgitation. The objective of this...
solaci -
Ver más
Day 2

IN.PACT Global Study: Pharmacological balloon in long lesions of the Superficial Femoral Artery (SFA)

Long lesions (≥ 15 cm), total occlusions, and in-stent restenosis represent a unique treatment challenge in peripheral...
solaci -
Ver más
Day 2

Angiographic TOTAL: Sub angiography studio of TOTAL

Myocardial blush is a predictor of mortality after primary angioplasty. Small studies showed a degree of improvement...
solaci -
Ver más
Day 2

TOTAL OCT: Thrombotic load of culprit lesion using OCT. TOTAL substudy.

The thrombotic load of culprit lesion is unidentified in the context of acute myocardial infarction that vindicates...
solaci -
Ver más
Day 2

OPINION: optical frequency domain versus IVUS to guide angioplasty

This multicenter, prospective, randomized controlled study was designed to evaluate the noninferiority of guided angioplasty by optical...
solaci -
Ver más
Day 2

CoreValve Evolut R CE: Good results at 6 months of the new CoreValve repositionable

This study evaluated the safety and efficacy of the new repositionable self-expanding valve. The primary end point...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad